HomeBUSINESS
BUSINESS

Japan Debut of MSD’s Zetia/Lipitor Combo Delayed as Cyberattack Woes Continue
(Oct.4.2017)

The Japan arm of US pharma giant Merck is to postpone the launch of its hypercholesterolemia agent Atozet (ezetimibe + atorvastatin), a fixed-dose combo of Zetia and Lipitor approved last week, as a June cyberattack against the company is taking a lingering toll on its global manufacturing operations ...
(LOG IN FOR FULL STORY)

News Calendar